Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Bayer Diagnostics Corp. — Predicate Candidate Screening

32 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

60 daysmedian FDA review time
168 days90th percentile
32clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K033379BAYER SPECIAL CHEMISTRY CONTROLSBayer Diagnostics Corp.2003-12-19580
K033380BAYER SPECIAL CHEMISTRY CALIBRATORSBayer Diagnostics Corp.2003-12-16550
K033007BAYER ADVIA DIGOXIN ASSAY FOR THE INTEGRATED MODULE SYSTEMBayer Diagnostics Corp.2003-11-14490
K031857ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAYBayer Diagnostics Corp.2003-09-04800
K022096URIC ACID ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2003-03-182640
K030452BAYER LIGAND PLUS 1, 2, 3 CONTROLSBayer Diagnostics Corp.2003-03-03200
K023840ACID PHOSPHATASE ASSAY FOR THE ADVIA 1650Bayer Diagnostics Corp.2003-01-07500
K023841AMMONIA ASSAY FOR THE ADVIA 1650Bayer Diagnostics Corp.2002-12-24360
K022177PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY FOR THE ADVIA INTEGRATBayer Diagnostics Corp.2002-12-171670
K022329CA 125 II ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEMBayer Diagnostics Corp.2002-11-271320
K023184ETHANOL ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEMBayer Diagnostics Corp.2002-11-18550
K022178CA 15-3 ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2002-11-121320
K022668ADVIA 120 HEMATOLOGY SYSTEM COMPLETE BLOOD COUNT (CBC) METHOBayer Diagnostics Corp.2002-10-15640
K020807AFP ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2002-10-012030
K022968ADVIA TESTPOINT CSF CONTROLBayer Diagnostics Corp.2002-09-24180
K022331ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHODBayer Diagnostics Corp.2002-09-11550
K020616BAYER RAPIDPOINT 405 SYSTEMBayer Diagnostics Corp.2002-07-171422
K021151AMMONIA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2002-07-13940
K020794SALICYLATE ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2002-07-111220
K020792ACETAMINOPHEN ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2002-07-111220
K021535ADVIA CANTAUR AND ACS:180 INSULIN CALIBRATORBayer Diagnostics Corp.2002-06-27482
K021532ADVIA CENTAUR AND ACS:180 C-PEPTIDE CALIBRATORBayer Diagnostics Corp.2002-06-27480
K020217ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAYBayer Diagnostics Corp.2002-03-15524
K012357CA 15-3 ASSAY FOR THE ADVIA CENTAUR SYSTEMBayer Diagnostics Corp.2002-02-282180
K013959BAYER VALPROIC ACID ASSAY FOR THE ACS:180 AND ADVIA CENTAUR Bayer Diagnostics Corp.2002-01-29600
K013750ADVIA 1650 CHOLINESTERASE ASSAYBayer Diagnostics Corp.2002-01-18660
K012183BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGG ASSAYBayer Diagnostics Corp.2001-12-271680
K013606ACS 180 HOMOCYSTEINE ASSAYBayer Diagnostics Corp.2001-12-21510
K013406ADVIA CENTAUR HOMOCYSTEINE ASSAYBayer Diagnostics Corp.2001-12-18642
K012904ADVIA 120 HEMATOLOGY SYSTEM, CYANIDE-FREE HIGH DETERMINATIONBayer Diagnostics Corp.2001-09-21230
K010050ADVIA CENTAUR AND ACS: 180 FOLATE IMMUNOASSAYBayer Diagnostics Corp.2001-02-053114
K003291BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR ANTI-TPO ASSAYBayer Diagnostics Corp.2000-12-05462

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda